Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults
Public ClinicalTrials.gov record NCT00361257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness of minocycline, an antibiotic, in lessening the decreased mental function sometimes caused by anti-HIV drugs.
Study identification
- NCT ID
- NCT00361257
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Dec 31, 2009
- Completion
- Dec 31, 2009
- Last update posted
- Feb 4, 2016
2007 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA-David Geffen School of Medicine | Los Angeles | California | 90035 | — |
| University of California | San Diego | California | 92103 | — |
| University of Colorado Health Science Center | Denver | Colorado | 80262-3706 | — |
| The Ponce de Leon Ctr. CRS | Atlanta | Georgia | 30308 | — |
| Northwestern University CRS | Chicago | Illinois | 60611 | — |
| Johns Hopkins School of Medicine | Baltimore | Maryland | 21287-8106 | — |
| Massachusetts General Hospital, Division of Infectious Diseases | Boston | Massachusetts | 02114 | — |
| Henry Ford Hosp. CRS | Detroit | Michigan | 48202 | — |
| Washington University | St Louis | Missouri | 63108-2138 | — |
| NYU Med Ctr, Dept of Medicine | New York | New York | 10016 | — |
| 1101 University of Rochester Medical Center, Division of Infectious Diseases | Rochester | New York | 14642 | — |
| University of North Carolina, AIDS Clinical Trials Unit | Chapel Hill | North Carolina | 27514 | — |
| The Research and Education Group - Portland CRS | Portland | Oregon | 97209 | — |
| University of Pennsylvania, ACTU | Philadelphia | Pennsylvania | 19104 | — |
| Virginia Commonwealth Univ. Medical Ctr. CRS | Richmond | Virginia | 23219 | — |
| Univ of Washington, Harborview Medical Ctr | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00361257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2016 · Synced Sep 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00361257 live on ClinicalTrials.gov.